Related Experiment Video
Updated: May 19, 2026

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
Published on: March 13, 2018
Recent advances in receptor-targeted fluorescent probes for in vivo cancer imaging
1Department of Radiology, University of Pittsburgh School of Medicine, PA 15219, USA. baim@upmc.edu
Abstract:
Receptor-targeted optical imaging of cancer is emerging as an attractive strategy for early cancer diagnosis and surgical guidance. The success of such strategy depends largely upon the development of receptor-targeted fluorescent probes with high specificity and binding affinity to the target receptors. Recently, a host of such probes have been reported to target cancer-specific receptors, such as somatostatin receptors (SSTRs), integrin receptors, cholecystokinin-2 (CCK(2)) receptor, gastrin-releasing peptide (GRP) receptor, endothelin A (ET(A)) receptor, translocator protein (TSPO) receptor, epidermal growth factor (EGF) receptor, human epidermal growth factor receptor 2 (HER2), vascular endothelial growth factor (VEGF) receptor, folate receptor (FR), transferrin receptor (TFR), low-density lipoprotein (LDL) receptors, type I insulin-like growth factor receptor (IGF1R), vasoactive intestinal peptide (VIP) receptors, urokinase plasminogen activator (uPA) and estrogen receptor (ER). This review will describe the recent advances in synthetic targeting optical imaging probes and demonstrate their in vivo imaging potentials. Moreover, current status of near infrared (NIR) fluorescent dyes, targeting moieties and coupling reactions, as well as strategies for designing targeted probes, will also be discussed.
Insights
Developing targeted fluorescent probes is key for early cancer detection and surgical guidance. This review covers advances in receptor-targeted optical imaging probes for improved cancer diagnosis.
Area of Science:
- Biomedical Imaging
- Molecular Imaging
- Cancer Diagnostics
Background:
- Receptor-targeted optical imaging offers a promising strategy for early cancer detection and surgical guidance.
- The efficacy of this approach relies on developing highly specific and high-affinity receptor-targeted fluorescent probes.
- Numerous probes targeting cancer-specific receptors have been reported, including SSTRs, integrins, and HER2.
Purpose of the Study:
- To review recent advancements in synthetic receptor-targeted optical imaging probes.
- To demonstrate the in vivo imaging potential of these novel probes.
- To discuss current developments in near-infrared fluorescent dyes, targeting moieties, and probe design strategies.
Main Methods:
- Literature review of recent advancements in receptor-targeted optical imaging probes.
- Analysis of synthetic strategies for probe development.
- Evaluation of in vivo imaging capabilities and targeting specificities.
Main Results:
- A wide array of receptor-targeted fluorescent probes have been developed for various cancer-specific receptors.
- These probes show significant potential for in vivo cancer imaging.
- Advances in near-infrared dyes, targeting ligands, and conjugation chemistries are enhancing probe performance.
Conclusions:
- Receptor-targeted optical imaging probes are crucial for improving early cancer diagnosis and surgical interventions.
- Continued research into probe design, targeting moieties, and imaging modalities will further enhance their clinical utility.
- The development of advanced fluorescent probes facilitates precise molecular imaging of cancer in vivo.
More Related Videos
12:24Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
10:55Fluorescence-quenching of a Liposomal-encapsulated Near-infrared Fluorophore as a Tool for In Vivo Optical Imaging
Published on: January 5, 2015